Nov 3, 2009
Story Timeline: 19 days
AllTranz, Inc., a specialty pharmaceutical company focused on developing drugs to treat a variety of neurologic and inflammatory disorders, today announced that it has been awarded a $4 million research grant from the National...
[read full story]
powered by 